Clinical Trial Update: Evaluation of the Therapeutic Effect of HU Pulse Therapy for CML Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating hydroxyurea pulse therapy for chronic myeloid leukemia; this update provides current status of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Leukemia, Chronic Myeloid | Phase 3 | Status: UNKNOWN